Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4337271Aexternal-prioritypatent/DE4337271A1/en
Priority claimed from DE4337270Aexternal-prioritypatent/DE4337270A1/en
Priority claimed from DE19944410881external-prioritypatent/DE4410881A1/en
Priority claimed from DE19944433928external-prioritypatent/DE4433928A1/en
Priority claimed from DE19944434288external-prioritypatent/DE4434288A1/en
Application filed by Хьохст Аг, Хехст АГfiledCriticalХьохст Аг
Publication of UA41318C2publicationCriticalpatent/UA41318C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The invention relates to novel chemical substances with precious pharmacological properties, in particular to heterocyclic derivatives of carboxylic acid of the general formula (I): (I) where: Q - oxygen, sulphur or NR', where R' denotes hydrogen or aryl with 6-12 atoms of carbon; A – alkylene with 1-4 atoms of carbon, unsubstituted or substituted by group -O-[CH2]x-CfH(2f+1-g)Halg, where: x denotes between 0 and 3, f – between 1 and 8, g between - 0.1 and (2f+1), a Hal - haloid, alkoxycarbonyl with 1-6 atoms of carbon in alkyl part, phenyl; B – carbonyl or group COOG, where: G represents non-branched or branched aliphatic alkyl with 1-16 atoms of carbon, R1, R2 and R3 are different and denote hydrogen, halogen, carboxyl, cycloalkylalkoxy.
UA94105979A1993-11-021994-10-31heterocyclic derivatives of carboxylic acid and their pharmaceutically acceptable salts
UA41318C2
(en)
N-substituted 3,4-dihydropyrimidine derivatives, process for the production thereof and composition containing same for treating disorders of cardiovascular system